Dr. Alexander Shoushtari
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Skin Cancer
Studies Melanoma
7 reported clinical trials
9 drugs studied
Area of expertise
1Skin Cancer
Stage IV
BRAF positive
GNA11 positive
2Melanoma
Stage IV
BRAF positive
PD-1 positive
Affiliated Hospitals
Clinical Trials Alexander Shoushtari is currently running
OBX-115
for Skin Cancer
This trial tests a new treatment called OBX-115 for adults with advanced solid tumors. It aims to see if the treatment is safe and effective by measuring its ability to shrink tumors, control disease progression, and improve survival.
Recruiting1 award Phase 1 & 211 criteria
Axitinib + Nivolumab
for Melanoma
The researchers are doing this study to find out whether the combination of axitinib and nivolumab is an effective and safe treatment for people with advanced or metastatic mucosal melanoma that has not been treated before. The researchers think that a combination of axitinib and nivolumab may help people with this disease because both drugs target and block proteins that play a role in cancer cell survival and growth. The researchers think the drugs may be more effective if given in combination rather than on their own.
Recruiting1 award Phase 2
More about Alexander Shoushtari
Clinical Trial Related4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Alexander Shoushtari has experience with
- Lifileucel (LN-144)
- Axitinib
- Nivolumab
- FHD-286
- OBX-115
- LXH254
Breakdown of trials Alexander Shoushtari has run
Skin Cancer
Eye Cancer
Uveal Melanoma
Liposarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alexander Shoushtari specialize in?
Alexander Shoushtari focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are BRAF positive.
Is Alexander Shoushtari currently recruiting for clinical trials?
Yes, Alexander Shoushtari is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Alexander Shoushtari has studied deeply?
Yes, Alexander Shoushtari has studied treatments such as Lifileucel (LN-144), Axitinib, Nivolumab.
What is the best way to schedule an appointment with Alexander Shoushtari?
Apply for one of the trials that Alexander Shoushtari is conducting.
What is the office address of Alexander Shoushtari?
The office of Alexander Shoushtari is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.